Why the study?
AF is associated with increased dementia risk in nonstroke populations, but whether it is associated with poststroke dementia remained unclear.
Does atrial fibrillation increase the risk of poststroke dementia in patients with acute ischemic stroke?
Does atrial fibrillation increase the risk of poststroke dementia in patients with acute ischemic stroke?
In patients with acute ischemic stroke, atrial fibrillation is not independently associated with an increased risk of poststroke dementia after adjusting for confounders, likely due to a higher competing risk of mortality.
Answers are grounded in this paper and cite their sources.
AF not independently tied to poststroke dementia after adjustment; leaves open competing mortality risks in this observational cohort.
BACKGROUND: Atrial fibrillation (AF) is associated with an increased risk of dementia in nonstroke populations. We aimed to study whether AF was also associated with an increased risk of poststroke dementia (PSD). METHODS: This nationwide register-based cohort study included all patients with incident acute ischemic stroke (AIS) in Denmark from 2008 to 2017. Patients with AF were compared with patients without AF using propensity-score weighting. The primary outcome was PSD, determined as a diagnosis of dementia or use of dementia medication within 5 years from AIS. PSD hazard rates were compared between patients with and without AF using Cox proportional hazards regression. Dementia-free mortality risk was evaluated as a secondary outcome. RESULTS: We included 61 058 patients with incident AIS, 12 248 with AF, and 48 810 without AF. Mean±SD age was 70.5±11.6, and 56.1% were men. A total of 3190 patients were diagnosed with dementia within a median of 2.1 (interquartile range, 0.82-4.2) years after AIS. In the unadjusted analysis, patients with AF had a higher PSD rate than patients without AF (19.0/1000 person-years versus 11.5/1000 person-years; hazard ratio [HR], 1.63 [95% CI, 1.51-1.77]). After adjustment for confounding factors, PSD risk was comparable between patients with and without AF (HR, 1.07 [95% CI, 0.97-1.17]). Dementia-free mortality risk was higher for patients with AF than patients without in both unadjusted (HR, 2.14 [95% CI, 2.07-2.21]) and adjusted analyses (HR, 1.31 [95% CI, 1.26-1.37]). CONCLUSIONS: Among patients with AIS, AF was not associated with an increased risk of PSD, likely due to an increased mortality risk. Patients with AF may not be a particular PSD high-risk group.
No takes yet. Share an insight, caveat, or question.
Vestergaard et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: